Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexinidazole in r-HAT
NCT03974178Phase 3Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Sep 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Fexinidazole in human African trypanosomiasis (HAT), sponsored by Drugs for Neglected Diseases initiative. Started Sep 2019; status: completed.
02
Drugs
Fexinidazole
03
Conditions
human African trypanosomiasis (HAT)
Beyond the preview
Go deeper on NCT03974178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03974178.